[Federal Register Volume 66, Number 7 (Wednesday, January 10, 2001)]
[Notices]
[Page 2003]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-758]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Importation of Controlled Substances; Notice of Application 
Correction

    In the Federal Register (FR Doc. 00-30294) Vol. 65, No. 229 at page 
70936, dated November 28, 2000, Cerilliant Corporation, 14050 Summit 
Drive, Suite 121, PO Box 80189, Austin, Texas 78708-0189, made 
application to the Drug Enforcement Administration to be registered as 
an importer for certain basic classes of controlled substances.
    The listing of controlled substance should not have included 
marihuana (7350) or tilidine (9750). Therefore, the above listed 
controlled substances are hereby deleted from Cerilliant Corporation's 
application for registration as an importer.
    The listing of controlled substance should have included etorphine 
(9056). Therefore, etorphine (9056) is hereby added to Cerilliant 
Corporation's application for registration as an importer.
    The firm plans to import small quantities of the listed controlled 
substance for the manufacture of analytical reference standards.
    Any manufacturer holding, or applying for, registration as a bulk 
manufacturer of this basic class of controlled substance may file 
written comments on or objections to the application described above 
and may, at the same time, file a written request for a hearing on such 
application in accordance with 21 CFR 1301.43 in such form as 
prescribed by 21 CFR 1316.47.
    Any such comments, objections or requests for a hearing may be 
addressed, in quintuplicate, to the Deputy Assistant Administrator, 
Office of Diversion Control, Drug Enforcement Administration, United 
States Department of Justice, Washington, DC 20537, Attention: DEA 
Federal Register Representative (CCR), and must be filed no later than 
(30 days from publication).
    This procedure is to be conducted simultaneously with and 
independent of the procedures described in 21 CFR 1301.34(b), (c), (d), 
(e), and (f). As noted in a previous notice at 40 FR 43745-46 
(September 23, 1975), all applicants for registration to import the 
basic class of any controlled substance in Schedule I or II are and 
will continue to be required to demonstrate to the Deputy Assistant 
Administrator, Office of Diversion Control, Drug Enforcement 
Administration that the requirements for such registration pursuant to 
21 U.S.C. 958(a), 21 U.S.C. 823(a), and 21 CFR 1301.34(a), (b), (c), 
(d), (e), and (f) are satisfied.

    Dated: December 14, 2000.
John H. King,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 01-758 Filed 1-9-01; 8:45 am]
BILLING CODE 4410-09-M